Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Chimeric monoclonal antibody against claudin-18 splice variant 2

EU orphan designation number: EU/3/13/1177   
Active ingredient: Chimeric monoclonal antibody against claudin-18 splice variant 2
Indication: Treatment of pancreatic cancer
Sponsor: GANYMED Pharmaceuticals AG
An der Golgrube 12, D-55131 Mainz, Deutschland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
08/08/2013 Centralised Orphan - Designation EMA/OD/071/13 (2013)5276 of 05/08/2013
24/10/2014 Centralised Orphan - Change of address